PBF-1681 (Ferric Citrate)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PBF-1681 (Ferric Citrate), covering 2025-06-29 to 2025-06-29. Get the full timeline:
Most recent: Clinical Trial Update: PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD [Phase 3]